References

Unresolved reference

2020 · External reference

Botulinum toxin in the management of temporomandibular disorders: a systematic review

10.1016/j.bjoms.2020.02.007 · 2020 · External reference

Research diagnostic criteria for temporomandibular disorders: a systematic review of axis I epidemiologic findings

10.1016/j.tripleo.2011.04.021 · 2011 · External reference

Temporomandibular joint pain and dysfunction

10.1007/s11916-006-0070-7 · 2006 · External reference

Efficacy of botulinum toxin therapy in treatment of myofascial pain

10.2334/josnusd.16-0614 · 2017 · External reference

Botulinum toxin therapy for temporomandibular joint disorders: a systematic review of randomized controlled trials

10.1016/j.ijom.2015.04.003 · 2015 · External reference

IncobotulinumtoxinA Injection for Temporomandibular Joint Disorder

10.1177/0003489417693013 · 2017 · External reference

Meta-analysis of Treatment Need for Temporomandibular Disorders in Adult Nonpatients

2008 · External reference

Hyaluronic acid injections for pain relief and functional improvement in patients with temporomandibular disorders: An umbrella review of systematic reviews

10.1111/joor.13571 · 2023 · External reference

Pharmacologic interventions in the treatment of temporomandibular disorders, atypical facial pain, and burning mouth syndrome. A qualitative systematic review

2003 · External reference

A randomized clinical trial of a tailored comprehensive care treatment program for temporomandibular disorders

2002 · External reference

Intra-articular injection of hyaluronic acid versus platelet-rich plasma following single puncture arthrocentesis for the management of internal derangement of TMJ: A double-blinded randomised controlled trial

10.1016/j.jcms.2022.10.002 · 2022 · External reference

Evaluation of the efficiency of hyaluronic acid, PRP and I-PRF intra-articular injections in the treatment of internal derangement of the temporomandibular joint: A prospective study

10.1016/j.jcms.2023.01.017 · 2023 · External reference

Arthrocentesis versus glucocorticosteroid injection for internal derangement of temporomandibular joint

2020 · External reference

Platelet-Rich Plasma Injection as an Effective Treatment for Temporomandibular Joint Osteoarthritis

10.1016/j.joms.2015.03.045 · 2015 · External reference

Long-Term Outcome of Arthrocentesis Plus Hyaluronic Acid Injection in Patients With Wilkes Stage II and III Temporomandibular Joint Internal Derangement

10.1097/scs.0000000000002078 · 2015 · External reference

The role of hyaluronic acid in protecting surface‐active phospholipids from lysis by exogenous phospholipase A2

10.1093/rheumatology/40.3.336 · 2001 · External reference

Hyaluronic acid’s biomechanical stabilization function in the temporomandibular joint

10.1097/00001665-200211000-00006 · 2002 · External reference

Osteoarthritis of the temporomandibular joint: an evaluation of the effects and complications of corticosteroid injection compared with injection with sodium hyaluronate

10.1111/j.1365-2842.2007.01759.x · 2007 · External reference

Single- or multiple-session viscosupplementation protocols for temporomandibular joint degenerative disorders: a randomized clinical trial

10.1111/joor.12282 · 2015 · External reference

Is arthrocentesis plus platelet-rich plasma superior to arthrocentesis plus hyaluronic acid for the treatment of temporomandibular joint osteoarthritis: a randomized clinical trial

10.1016/j.ijom.2016.06.009 · 2016 · External reference

Comparison of intra-articular injection of plasma rich in growth factors versus hyaluronic acid following arthroscopy in the treatment of temporomandibular dysfunction: A randomised prospective study

10.1016/j.jcms.2017.01.010 · 2017 · External reference

Clinical and Radiological Comparison of Effects of Platelet-Rich Plasma, Hyaluronic Acid, and Corticosteroid Injections on Temporomandibular Joint Osteoarthritis

2019 · External reference

Medium-Term Effect of Treatment with Intra-Articular Injection of Sodium Hyaluronate, Betamethasone and Platelet-Rich Plasma in Patients with Temporomandibular Arthralgia: A Retrospective Cohort Study

2022 · External reference

Ozone for the treatment of temporomandibular joint disorders: a systematic review and meta-analysis

10.4103/2045-9912.345174 · 2023 · External reference

Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review)

10.1212/01.wnl.0000311390.87642.d8 · 2008 · External reference

Proteolysis of SNAP-25 by types E and A botulinal neurotoxins.

10.1016/s0021-9258(17)42071-0 · 1994 · External reference

Temporomandibular Myofacial Pain Treated with Botulinum Toxin Injection

10.3390/toxins7082791 · 2015 · External reference

Is there enough evidence to use botulinum toxin injections for bruxism management? A systematic literature review

10.1007/s00784-017-2092-4 · 2017 · External reference

BTX-A for persistent myofascial TMD pain: Interpreting a small clinical trial with negative results

10.1016/j.pain.2011.05.020 · 2011 · External reference

Botulinum toxin type a induces direct analgesic effects in chronic neuropathic pain

10.1002/ana.21427 · 2008 · External reference

Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: Recommendations of the International RDC/TMD Consortium Network and Orofacial Pain Special Interest Group,

10.11607/jop.1151 · 2014 · External reference

Clinical outcomes of Botox injections for chronic temporomandibular disorders: do we understand how Botox works on muscle, pain, and the brain

10.1016/j.ijom.2016.11.004 · 2017 · External reference

Treatment of Temporomandibular Disorders with Botulinum Toxin

10.1097/00002508-200211001-00013 · 2002 · External reference

The emerging role of botulinum toxin in the treatment of temporomandibular disorders

10.1111/j.1601-0825.2007.01352.x · 2007 · External reference

Botulinum injection for the management of myofascial pain in the masticatory muscles. A prospective outcome study

2013 · External reference

The PRISMA 2020 statement: an Updated Guideline for Reporting Systematic Reviews

2021 · External reference

RoB 2: a revised tool for assessing risk of bias in randomised trials

10.1136/bmj.l4898 · 2019 · External reference

Treatment of chronic pain associated with nocturnal bruxism with botulinum toxin. A prospective and randomized clinical study

2016 · External reference

The effect of laser and botulinum toxin in the treatment of myofascial pain and mouth opening: A randomized clinical trial

10.1016/j.jphotobiol.2016.03.038 · 2016 · External reference

Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: A randomized, controlled, double-blind multicenter study

10.1016/j.pain.2011.03.036 · 2011 · External reference

Efficacy of Botulinum Toxin in Treating Myofascial Pain in Bruxers: A Controlled Placebo Pilot Study

10.1179/crn.2008.017 · 2008 · External reference

Myofascial Pain of the Jaw Muscles: Comparison of Short-Term Effectiveness of Botulinum Toxin Injections and Fascial Manipulation Technique

10.1179/crn.2012.014 · 2012 · External reference

Effect of Botulinum Toxin on Masticatory Muscle Pain in Patients with Temporomandibular Disorders: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

10.3390/toxins15100597 · 2023 · External reference

Effect of Botulinum Toxin-A in Myofascial Pain Patients With or Without Functional Disc Displacement

10.1016/j.joms.2008.03.008 · 2008 · External reference

Effect of Botulinum Toxin Injection on Nocturnal Bruxism

10.1097/phm.0b013e3181bc0c78 · 2010 · External reference

Randomized controlled trial of botulinum toxin A for chronic myogenous orofacial pain

10.1016/s0304-3959(02)00240-3 · 2002 · External reference

Onabotulinum toxin-A injections for sleep bruxism

2018 · External reference

Efficacy of botulinum toxin in treating myofascial pain and occlusal force characteristics of masticatory muscles in bruxism

10.4103/ijdr.ijdr_125_17 · 2017 · External reference

Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity

10.1016/s0278-2391(03)00153-8 · 2003 · External reference

Occlusal force characteristics of masseteric muscles after intramuscular injection of botulinum toxin A(BTX–A)for treatment of temporomandibular disorder,"

10.1016/j.bjoms.2016.04.008 · 2016 · External reference

Effects of exercise therapy on painful temporomandibular disorders.

External reference

Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group†.

10.11607/jop.1151 · 2014 · External reference

Temporomandibular Disorders and Vitamin D Deficiency: What Is the Linkage between These Conditions? A Systematic Review.

10.3390/jcm11216231 · 2022 · External reference

Management of pain in patients with temporomandibular disorder (TMD): challenges and solutions

10.2147/jpr.s127950 · 2018 · External reference